Marcela C. Smid
( out of 23 reviews )

Marcela C. Smid, MD, MS, MA

Languages spoken: Spanish, English, Czech

Clinical Locations

Primary Location

University of Utah Hospital

University Maternal Fetal Medicine, Area E
50 N Medical Dr
Salt Lake City , UT 84132
801-213-2995
Get Directions

South Jordan Health Center

5126 West Daybreak Parkway
South Jordan , UT 84009
801-213-4500
Get Directions

A specialist in Maternal-Fetal Medicine, Dr. Marcela Smid is an addiction medicine physician. Dr. Smid is the medical director of the Substance Use & Pregnancy – Recovery, Addiction, Dependence (SUPeRAD) specialty prenatal clinic. This multi-disciplinary clinic provides care to those who are pregnant and postpartum individuals with substance use disorders, providing tailored care and support.

Dr. Smid is involved in pioneering research focused on perinatal addiction, effective interventions for pregnant and postpartum individuals with substance use disorders, maternal mortality, and maternal mental health. Her interests also extend to managing pregnancy after bariatric surgery, with prior research aimed at enhancing care for individuals with obesity.

She earned her BA in Medical Anthropology, with minors in Chemistry and Art History, and an MA in Medical Anthropology with a concentration in International Health from Case Western Reserve University. She also received her MD through a joint medical program between the University of California, San Francisco, and the University of California, Berkeley, where she then completed her MS in Health and Medical Sciences. Following her graduate training, Dr. Smid completed her residency in Obstetrics and Gynecology at the University of Chicago Medical Center, where she also served as Academic Chief Resident. She then pursued a fellowship in Maternal Fetal Medicine at the University of North Carolina at Chapel Hill.

Dr. Smid is board certified by the American Board of Obstetrics & Gynecology in both General Obstetrics & Gynecology and Maternal-Fetal Medicine, as well as by the American Board of Preventive Medicine in Addiction Medicine. She has been an active member of the Utah Perinatal Mortality Committee since 2016. In addition to her clinical practice, Dr. Smid is an Assistant Professor in the departments of Obstetrics & Gynecology (Primary) and Psychiatry (Adjunct) at the University of Utah. She is a member of the Adult Psychiatry and Maternal Fetal Medicine academic divisions, contributing significantly to both education and patient care.

Specialties

Board Certification

American Board of Obstetrics & Gynecology (Sub: Complex Family Planning) (ABOG)
American Board of Obstetrics & Gynecology (Sub: Maternal-Fetal Medicine)
American Board of Preventive Medicine (Addiction Medicine)
American Board of Obstetrics & Gynecology

Patient Rating

4.9 /5
( out of 23 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

2026-01-13
EXTERNAL SITE

I never feel as though I am a number. She always takes the time to make me feel included in my care and recognized as an individual.

2025-10-17
UNIVERSITY HOSPITAL

She's an amazing person, positive attitude and very helpful and respectful

2025-10-03
EXTERNAL SITE

What a fantastic provider

2025-08-06
UNIVERSITY HOSPITAL

An amazing physician always greets with a warm welcome. Makes you feel comfortable and easy to talk to. Answers any questions without seeming rushed.

2025-08-03
UNIVERSITY HOSPITAL

She's amazing

2025-04-10
EXTERNAL SITE

I love Dr. Smid [TRANSLATED]

2025-04-09
EXTERNAL SITE

She's very very sweet attentive and kind as well as in depth detail anything she forgot or felt like I deserved to know she sent me a message of after the appointment which I appreciate so much she's amazing!

2024-12-07
MEMORIAL HOSP SWEETWATER COUNTY

She is so kind and caring. I feel like she's actually listening to my complaints and how I'm feeling. She let's me know the truth and what realistic expectations are.

2024-10-31
UH HOSPITALS AND CLINICS

She's simply the best. I think she provides amazing care to people who are scared, nervous and anxious!

A specialist in Maternal-Fetal Medicine, Dr. Marcela Smid is an addiction medicine physician. Dr. Smid is the medical director of the Substance Use & Pregnancy – Recovery, Addiction, Dependence (SUPeRAD) specialty prenatal clinic. This multi-disciplinary clinic provides care to those who are pregnant and postpartum individuals with substance use disorders, providing tailored care and support.

Dr. Smid is involved in pioneering research focused on perinatal addiction, effective interventions for pregnant and postpartum individuals with substance use disorders, maternal mortality, and maternal mental health. Her interests also extend to managing pregnancy after bariatric surgery, with prior research aimed at enhancing care for individuals with obesity.

She earned her BA in Medical Anthropology, with minors in Chemistry and Art History, and an MA in Medical Anthropology with a concentration in International Health from Case Western Reserve University. She also received her MD through a joint medical program between the University of California, San Francisco, and the University of California, Berkeley, where she then completed her MS in Health and Medical Sciences. Following her graduate training, Dr. Smid completed her residency in Obstetrics and Gynecology at the University of Chicago Medical Center, where she also served as Academic Chief Resident. She then pursued a fellowship in Maternal Fetal Medicine at the University of North Carolina at Chapel Hill.

Dr. Smid is board certified by the American Board of Obstetrics & Gynecology in both General Obstetrics & Gynecology and Maternal-Fetal Medicine, as well as by the American Board of Preventive Medicine in Addiction Medicine. She has been an active member of the Utah Perinatal Mortality Committee since 2016. In addition to her clinical practice, Dr. Smid is an Assistant Professor in the departments of Obstetrics & Gynecology (Primary) and Psychiatry (Adjunct) at the University of Utah. She is a member of the Adult Psychiatry and Maternal Fetal Medicine academic divisions, contributing significantly to both education and patient care.

Board Certification and Academic Information

Academic Departments Psychiatry -Adjunct Associate Professor
Obstetrics & Gynecology -Associate Professor
Academic Divisions Maternal Fetal Medicine
Adult Psychiatry
Board Certification
American Board of Obstetrics & Gynecology (Sub: Complex Family Planning) (ABOG)
American Board of Obstetrics & Gynecology (Sub: Maternal-Fetal Medicine)
American Board of Preventive Medicine (Addiction Medicine)
American Board of Obstetrics & Gynecology

Education history

Undergraduate Major: Medical Anthropology; Minors: Chemistry, Art History - Case Western Reserve University B.A.
Graduate Training Medical Anthropology, Concentration: International Health - Case Western Reserve University M.A.
Graduate Training Health and Medical Sciences - University of California, Berkeley M.S.
Professional Medical Joint Medical Program - University of California, San Francisco/University of California, Berkeley M.D.
Internship Obstetrics and Gynecology - University of Chicago Medical Center Intern
Residency Obstetrics and Gynecology - University of Chicago Medical Center Resident
Chief Resident Obstetrics and Gynecology - University of Chicago Medical Center Academic Chief Resident
Fellowship Maternal Fetal Medicine - University of North Carolina at Chapel Hill Fellow

Selected Publications

Journal Article

  1. Smid MC, Stone NM, Baksh L, Debbink MP, Einerson BD, Varner MW, Gordon AJ, Clark EA (2019). Pregnancy-Associated Death in Utah: Contribution of Drug-Induced Deaths. Obstetrics and gynecology, 133(6), 1131–1140. https://doi.org/10.1097/AOG.0000000000003279 PMID: 31135726    . Obstetrics and gynecology, 133(6), 1131-1140.
  2. Smid M (2019). Marijuana use among young pregnant women: more common and more harmful than we think. BJOG: an international journal of obstetrics and gynaecology, 126(12), 1498. https://doi.org/10.1111/1471-0528.15919 PMID: 31454457. BJOG, 126(12), 1498.
  3. Cassimatis IR, Battarbee AN, Allshouse AA, Badreldin N, Vranes CM, Oler AM, Smid M (2020). Neonatal outcomes associated with late preterm betamethasone administration in women with pregestational diabetes. Pediatrics & Neonatology, 61(6), 645–646. https://doi.org/10.1016/j.pedneo.2020.07.002 PMID: 32763054. Pediatrics and neonatology, 61(6), 645-646.
  4. Cleary EM, Smid MC, Bokat C, Costantine MM, Rood K (2021). Indicated Opioids in Pregnancy: Guidance on Providing Comprehensive Care. American Journal of Perinatology. https://doi.org/10.1055/s-0041-1739427 PMID: 34768306. American journal of perinatology,
  5. D'Alton ME, Rood KM, Smid MC, Simhan HN, Skupski DW, Subramaniam A, Gibson KS, Rosen T, Clark SM, Dudley D, Iqbal SN, Paglia MJ, Duzyj CM, Chien EK, Gibbins KJ, Wine KD, Bentum NAA, Kominiarek MA, Tuuli MG, Goffman (2020). Intrauterine Vacuum-Induced Hemorrhage-Control Device for Rapid Treatment of Postpartum Hemorrhage. Obstetrics & Gynecology, 136(5), 882–891. https://doi.org/10.1097/aog.0000000000004138 PMID: 32909970 . Obstetrics and gynecology, 136(5), 882-891.
  6. Debbink MP, Metz TD, Nelson RE, Janes SE, Kroes A, Begaye LJ, Heuser CC, Smid MC, Silver RM, Varner MW, Einerson B (2021). Directly Measured Costs of Severe Maternal Morbidity Events during Delivery Admission Compared with Uncomplicated Deliveries. American Journal of Perinatology. https://doi.org/10.1055/s-0041-1740237 PMID: 34856617. American journal of perinatology, 39(6), 567-576.
  7. Dude AM, Smid MC, Branch DW, West J, Meeks H, Yu Z, Fraser A, Smith K, Reddy (2021). Interpregnancy Body Mass Index Change and Offspring Mortality Risk following the Second Pregnancy. American Journal of Perinatology. https://doi.org/10.1055/s-0041-1727230 PMID: 33878768 . American journal of perinatology, 40(4), 387-393.
  8. Kelley AT, Smid MC, Baylis JD, Charron E, Begaye LJ, Binns-Calvey A, Archer S, Weiner S, Pettey W, Cochran (2021). Treatment access for opioid use disorder in pregnancy among rural and American Indian communities. J Subst Abuse Treat. 2022 May;136:108685. doi: 10.1016/j.jsat.2021.108685. Epub 2021 Dec 13. PMID: 34953636. Journal of substance abuse treatment, 136, 108685.
  9. Metz TD, Allshouse AA, Pinar H, Varner M, Smid MC, Hogue C, Dudley DJ, Bukowski R, Saade GR, Goldenberg RL, Reddy U, Silver R (2020). Maternal Marijuana Exposure, Feto-Placental Weight Ratio, and Placental Histology. American Journal of Perinatology. https://doi.org/10.1055/s-0040-1717092 PMID: 32971561 . American journal of perinatology,
  10. Reese SE, Riquino MR, Molloy J, Nguyen V, Smid MC, Tenort B, Gezinski L (2021). Experiences of Nursing Professionals Working With Women Diagnosed With Opioid Use Disorder and Their Newborns: Burnout and the Need for Support. Advances in Neonatal Care, 21(1), 32–40. https://doi.org/10.1097/anc.0000000000000816 PMID: 33055519. Advances in neonatal care, 21(1), 32-40.
  11. Smid MC, Schauberger CW, Terplan M, Wright T (2020). Early lessons from maternal mortality review committees on drug-related deaths-time for obstetrical providers to take the lead in addressing addiction. American Journal of Obstetrics & Gynecology MFM, 2(4). https://doi.org/10.1016/j.ajogmf.2020.100177 PMID: 33345905. American journal of obstetrics & gynecology MFM, 2(4), 100177.
  12. Smid MC, Terplan (2022). What Obstetrician-Gynecologists Should Know About Substance Use Disorders in the Perinatal Period. Obstet Gynecol. 2022 Feb 1;139(2):317-337. doi: 10.1097/AOG.0000000000004657. PMID: 34991147. Obstetrics and gynecology,
  13. Cochran G, Smid MC, Krans EE, Bryan MA, Gordon AJ, Lundahl B, Silipigni J, Haaland B, Tarter (2019). A pilot multisite study of patient navigation for pregnant women with opioid use disorder. Contemp Clin Trials. 87:105888. doi: 10.1016/j.cct.2019.105888. Epub 2019 Nov 12. PMID:31731006. Contemporary clinical trials, 87, 105888.
  14. Dotters-Katz SK, Smid MC, Tinkham S, & Chuang (2019). Impact of Preclinical Labor and Delivery Shadowing on Student Perceptions of Obstetrics and Gynecology as a Specialty and Possible Career: A Prospective Cohort. AJP Reports. DOI: 10.1055/s-0039-1695747. AJP reports, 9(4), e361-e365.
  15. Charron E, Baylis JD, Archer S, Garets M, Bryan MA, Foringer J, Kelley AT, Smid MC, Cochran G (2022). Attitudes, Self-Efficacy, and Practices Related to Opioid Risk Assessment and Mitigation: A Comparison of Health Care Professionals in Rural Communities. Subst Abus. (In Press). Journal of substance abuse,
  16. Rood KM, Bianco A, Biggio JR, Smid MC, Simhan HN, Li J, Yong C, Carney PI, Croft DJ, Goffman (2025). Real-world use of a vacuum-induced hemorrhage-control device in births <34 weeks gestational age. The journal of maternal-fetal & neonatal medicine, 38(1), 2451658.
  17. Board A, Vivolo-Kantor A, Kim SY, Tran EL, Thomas SA, Terplan M, Smid MC, Sanjuan PM, Wright T, Davidson A, Wachman EM, Rood KM, Morse D, Chu E, Miele (2025). Using ICD Codes Alone May Misclassify Overdoses Among Perinatal People. American journal of preventive medicine, 68(3), 563-570.
  18. Atluru S, Bruehlman AK, Vaughn P, Schauberger CW, Smid M (2024). Naltrexone Compared With Buprenorphine or Methadone in Pregnancy: A Systematic Review. Obstetrics and gynecology, 143(3), 403-410.
  19. Smid MC, Clifton RG, Rood K, Srinivas S, Simhan HN, Casey BM, Longo M, Landau R, MacPherson C, Bartholomew A, Sowles A, Reddy UM, Rouse DJ, Bailit JL, Thorp JM Jr, Chauhan SP, Saade GR, Grobman WA, Macones GA, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network (2024). Optimizing Opioid Prescription Quantity After Cesarean Delivery: A Randomized Controlled Trial. Obstetrics and gynecology, 144(2), 195-205.
  20. Nabi R, Bonvini M, Kennedy EH, Huang MY, Smid M, Scharfstein D (2024). Semiparametric sensitivity analysis: unmeasured confounding in observational studies. Biometrics, 80(4),
  21. Cochran G, Smid MC, Krans EE, Yu Z, Carlston K, White A, Abdulla W, Baylis J, Charron E, Okifugi A, Gordon AJ, Lundahl B, Silipigni J, Seliski N, Haaland B, Tarter (2024). Patient navigation for pregnant individuals with opioid use disorder: Results of a randomized multi-site pilot trial. Addiction (Abingdon, England), 119(3), 544-556.
  22. Kurtz T, Charron E, Shakib J, Smid M (2024). Drug Testing Interpretation in the Peripartum Setting: Results of Clinician Survey. Journal of addiction medicine, 18(5), 595-598.
  23. Smid MC, Vaughn P, Nowicki CC, Goodman DA, Zaharatos J, Campbell K (2024). Consensus pregnancy-related criteria for suicide and unintentional overdoses using a Delphi process. Archives of women's mental health, 27(1), 109-125.
  24. Maylott SE, Reese SE, Zhou AM, Kaliush PR, Terrell S, Saenz C, Brown L, Crowell SE, Lester B, Smid MC, Shakib JH, Garland EL, Conradt (2024). Maternal psychophysiology profiles: associations with prenatal opioid use, maternal emotion dysregulation, and newborn neurobehavior. Pediatric research,
  25. Seliski N, Madsen T, Eley S, Colosimo J, Engar T, Gordon A, Barnett C, Humiston G, Morsillo T, Stolebarger L, Smid MC, Cochran (2024). Implementation of a rural emergency department-initiated buprenorphine program in the mountain west: a study protocol. Addiction science & clinical practice, 19(1), 63.
  26. Jawish R, Smid M, Gordon A, Shangraw K, Mickey B (2024). Prolonged transcranial magnetic stimulation in a pregnant patient with treatment-resistant depression: a case report. Journal of medical case reports, 18(1), 512.
  27. Iacob E, Kausler R, Williams M, Simonsen S, Smid M, Weissinger K, Latendresse (2024). Protocol for a randomized controlled trial to evaluate the effectiveness of a telehealth group intervention to reduce perinatal depressive symptoms. Contemporary clinical trials, 147, 107738.
  28. Tran EL, Dorsey AN, Miele K, Gilboa SM, Gosdin L, Terplan M, Sanjuan PM, Seligman NS, Wright T, Wachman EM, Smid M, Henninger M, Leeman L, Schneider PD, Rood K, Louis JM, Caveglia S, Davidson A, Shakib J, Shrestha H, Meaney-Delman DM, Kim S (2024). Patterns of Medication for Opioid Use Disorder During Pregnancy, 7 Clinical Sites, MATernaL and Infant clinical NetworK (MAT-LINK), 2014-2021. Journal of addiction medicine,
  29. Herrera CA, McPherson JA, Vladutiu CJ, Smid M (2023). Neonatal morbidity associated with maternal Group B Streptococcal colonization in individuals undergoing planned cesarean delivery. The journal of maternal-fetal & neonatal medicine, 36(1), 2183740.
  30. Charron E, White A, Carlston K, Abdullah W, Baylis JD, Pierce S, Businelle MS, Gordon AJ, Krans EE, Smid MC, Cochran (2023). Prospective acceptability of digital phenotyping among pregnant and parenting people with opioid use disorder: A multisite qualitative study. Frontiers in psychiatry, 14, 1137071.
  31. Bruno AM, Horns JJ, Allshouse AA, Metz TD, Debbink ML, Smid M (2023). Association Between Periviable Delivery and New Onset of or Exacerbation of Existing Mental Health Disorders. Obstetrics and gynecology, 141(2), 395-402.
  32. Herrera CA, McPherson JA, Vladutiu CJ, Smid M (2023). Neonatal morbidity associated with maternal Group B Streptococcal colonization in individuals undergoing planned cesarean delivery. The journal of maternal-fetal & neonatal medicine, 36(1), 2183740.
  33. Smid MC, Allshouse AA, McMillin GA, Nunez K, Cavin T, Worden J, Buchi K, Muniyappa B, Varner MW, Cochran G, Metz T (2022). Umbilical Cord Collection and Drug Testing to Estimate Prenatal Substance Exposure in Utah. Obstetrics and gynecology, 140(2), 153-162.
  34. Kurtz T, Smid M (2022). Challenges in Perinatal Drug Testing. Obstetrics and gynecology, 140(2), 163-166.
  35. Smid MC, Metz TD, McMillin GA, Mele L, Casey BM, Reddy UM, Wapner RJ, Thorp JM, Saade GR, Tita ATN, Miller ES, Rouse DJ, Sibai B, Costantine MM, Mercer BM, Caritis SN, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network (2022). Prenatal Nicotine or Cannabis Exposure and Offspring Neurobehavioral Outcomes. Obstetrics and gynecology, 139(1), 21-30.
  36. Kelley AT, Smid MC, Baylis JD, Charron E, Binns-Calvey AE, Archer S, Weiner SJ, Begaye LJ, Cochran (2021). Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities. Addiction science & clinical practice, 16(1), 40.
  37. Page JM, Allshouse AA, Cassimatis I, Smid MC, Arslan E, Thorsten V, Parker C, Varner MW, Dudley DJ, Saade GR, Goldenberg RL, Stoll BJ, Hogue CJ, Bukowski R, Conway D, Pinar H, Reddy UM, Silver R (2020). Characteristics of Stillbirths Associated With Diabetes in a Diverse U.S. Cohort. Obstetrics and gynecology, 136(6), 1095-1102.
  38. Smid MC, Maeda J, Stone NM, Sylvester H, Baksh L, Debbink MP, Varner MW, Metz T (2020). Standardized Criteria for Review of Perinatal Suicides and Accidental Drug-Related Deaths. Obstetrics and gynecology, 136(4), 645-653.
  39. Bryan MA, Smid MC, Cheng M, Fortenberry KT, Kenney A, Muniyappa B, Pendergrass D, Gordon AJ, Cochran (2020). Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol. Addiction science & clinical practice, 15(1), 33.
  40. Venkatesh KK, Pate V, Boggess KA, Jones HE, Funk MJ, Smid M (2020). Trends in Opioid and Psychotropic Prescription in Pregnancy in the United States From 2001 to 2015 in a Privately Insured Population : A Cross-sectional Study. Annals of internal medicine, 173(11 Suppl), S19-S28.
  41. Dotters-Katz S, Panzer A, Givens M, Smid M, Chuang (2018). Preclinical Labor-and-Delivery Shadowing: The Impact on Medical Students' Perceptions of Obstetrics and Gynecology. AJP reports, 8(2), e64-e67.
  42. Smid MC, Dotters-Katz SK, Vaught AJ, Vladutiu CJ, Boggess KA, Stamilio D (2017). Maternal super obesity and risk for intensive care unit admission in the MFMU Cesarean Registry. Acta obstetricia et gynecologica Scandinavica, 96(8), 976-983.
  43. Smid M (2019). Marijuana use among young pregnant women: more common and more harmful than we think. BJOG, 126(12), 1498.
  44. Debbink MP, Metz TD, Nelson RE, Janes SE, Kroes A, Begaye LJ, Heuser CC, Smid MC, Silver RM, Varner MW, Einerson B (2022). Directly Measured Costs of Severe Maternal Morbidity Events during Delivery Admission Compared with Uncomplicated Deliveries. American journal of perinatology, 39(6), 567-576.
  45. Penfield-Cyr A, Monthe-Dreze C, Smid MC, Sen (2018). Maternal BMI, Mid-pregnancy Fatty Acid Concentrations,and Perinatal Outcomes. Clinical therapeutics, 40(10), 1659-1667.e1.
  46. White A, Lundahl B, Bryan MA, Okifuji A, Smid M, Gordon AJ, Carlston K, Silipigni J, Abdullah W, Krans EE, Kenney A, Cochran (2022). Pregnancy and the Opioid Crisis: Heightened Effects of COVID-19. Journal of addiction medicine, 16(1), e2-e4.

Review

  1. Schauberger CW, Smid MC, Terplan M, Wright T (2025). Lessons from Maternal Mortality Reviews. How Addiction Care Providers can help improve Outcomes for Pregnant, Postpartum, and Parenting people. Substance use & misuse, 60(3), 446-451.
  2. Gimbel LA, Weingarten SJ, Smid MC, Hoffman M (2024). Maternal mental health as a major contributor to maternal mortality. Seminars in perinatology, 48(6), 151943.
  3. McMillin GA, Morad AW, Boyd JM, Johnson-Davis KL, Metz TD, Smid MC, Krasowski M (2024). Biological Testing and Interpretation of Laboratory Results Associated with Detecting Newborns with Substance Exposure. Clinical chemistry, 70(7), 934-947.
  4. Kurtz T, Smid M (2023). Office-Based Management of Perinatal Substance Use and Substance Use Disorder for the General Obstetrician-Gynecologist. Obstetrics and gynecology clinics of North America, 50(3), 609-627.
  5. Park Y, Dang EP, Board A, Gilboa SM, Ondersma SJ, Smid MC, Shakib JH, Mitchell KT, England LJ, Broussard CS, Meaney-Delman D, Iskander J, Kim S (2023). Polysubstance Use in Pregnancy: Surveillance, Interventions, and Next Steps. Journal of women's health (2002), 32(9), 899-904.
  6. Cleary EM, Smid MC, Charles JE, Jones KM, Costantine MM, Saade G, Rood K (2021). Buprenorphine X-waiver exemption - beyond the basics for the obstetrical provider. American journal of obstetrics & gynecology MFM, 3(6), 100451.

Editorial

  1. Smid MC, Saitz (2021). Postpartum Treatment of Individuals With Opioid Use Disorder: Maternal Risk and Need for Evidence Do Not End When Pregnancy Ends. Journal of addiction medicine, 15(4), 267-268.

Letter

  1. Xu KY, Pappas LM, Brown TR, Jansen MO, Tardelli VS, Fidalgo TM, Levin FR, Grucza RA, Suarez EA, Smid MC, Horns JJ, Bruno A (2025). Attention-deficit hyperactivity disorder medication discontinuation during pregnancy and resumption postpartum. American journal of obstetrics & gynecology MFM, 7(4), 101625.
  2. Smid MC, Allshouse AA, Metz TD, Debbink MP, Charron E, Campbell K, Cochran (2024). Co-occurring opioid and methamphetamine use disorder and severe maternal morbidity and mortality in Utah. American journal of obstetrics & gynecology MFM, 6(1), 101221.
  3. Metz TD, Allshouse AA, McMillin GA, Silver RM, Smid MC, Haas DM, Simhan HN, Saade GR, Grobman WA, Parry S, Chung JH, Jarlenski M (2022). Association of Cannabis Use With Nausea and Vomiting of Pregnancy. Obstetrics and gynecology, 140(2), 266-270.

Other

  1. Scharfstein DO, Nabi R, Kennedy EH, Huang M, Bonvini M, Smid M (2021). Semiparametric Sensitivity Analysis: Unmeasured Confounding In Observational Studies.

News & Podcasts

News